Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 192,499 | 307,064 | 354,786 | 116,922 | N/A |
| Marketable Securities | 186,414 | 96,987 | 54,088 | 64,808 | N/A |
| Other current assets | 122 | 622 | 122 | 122 | 0 |
| TOTAL | $385,834 | $414,410 | $412,488 | $182,817 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 24,577 | 62,796 | 39,208 | 21,130 | N/A |
| Other Non-Current Assets | 31,059 | 1,903 | 1,102 | 3,586 | 0 |
| TOTAL | $55,636 | $64,699 | $40,310 | $24,716 | $N/A |
| Total Assets | $441,470 | $479,109 | $452,798 | $207,533 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,222 | 306 | N/A |
| Accounts payable and accrued liabilities | 10,200 | 7,886 | 4,542 | 6,967 | 0 |
| Accrued Expenses | 5,975 | 12,118 | 10,245 | 7,635 | N/A |
| TOTAL | $20,700 | $20,004 | $16,009 | $14,908 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,431 | 24,347 | 4,245 | 5,156 | N/A |
| Other Non-Current Liabilities | 24,703 | 309 | 187 | 2,850 | 0 |
| TOTAL | $49,134 | $66,097 | $25,782 | $22,558 | $N/A |
| Total Liabilities | $69,834 | $86,101 | $41,791 | $37,466 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 79,932 | 79,530 | 79,044 | 79,043 | N/A |
| Common Shares | 80 | 79 | 79 | 15 | N/A |
| Retained earnings | -181,863 | -150,082 | -122,899 | -105,333 | N/A |
| Other shareholders' equity | 81 | -29 | -19 | 240,749 | 0 |
| TOTAL | $371,636 | $393,008 | $411,007 | $170,067 | $N/A |
| Total Liabilities And Equity | $441,470 | $479,109 | $452,798 | $207,533 | $0 |